Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Droller

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Urology|July 26, 2002
Evaluation of the clinical value of urinary NMP22 as a marker for screening and surveillance of transitional cell carcinoma of the urinary bladderMichael J Droller
The Journal of Urology|October 29, 2002
Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinomaMichael J Droller
Urologic Oncology|May 16, 2020
Letter from the Editor, "Thank you", Michael J. Droller, M.DMichael J Droller
The Journal of Urology|November 7, 2003
Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladderMichael J Droller
The Journal of Urology|November 6, 2003
Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladderMichael J Droller
The Journal of Urology|November 6, 2003
Expression of cathepsin D in urothelial carcinoma of the urinary bladder: an immunohistochemical study including correlations with extracellular matrix components, CD44, p53, Rb, c-erbB-2 and the proliferation indicesMichael J Droller
Urologic Oncology|February 22, 2021
Urologic Oncology: Seminars and Original Investigations. A Twenty-Fifth Anniversary HistoryMichael J Droller
Urology|October 1, 2005
Biological considerations in the assessment of urothelial cancer: a retrospectiveMichael J Droller
The Journal of Urology|August 12, 2005
Public education: the AUA and AUA foundationMichael J Droller
European Urology|December 7, 2007
Words of wisdom. Re: Surveillance for recurrent bladder cancer using a point-of-care proteomic assayMichael J Droller
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Urology|July 26, 2002
Evaluation of the clinical value of urinary NMP22 as a marker for screening and surveillance of transitional cell carcinoma of the urinary bladderMichael J Droller
The Journal of Urology|October 29, 2002
Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinomaMichael J Droller
Urologic Oncology|May 16, 2020
Letter from the Editor, "Thank you", Michael J. Droller, M.DMichael J Droller
The Journal of Urology|November 7, 2003
Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladderMichael J Droller
The Journal of Urology|November 6, 2003
Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladderMichael J Droller
The Journal of Urology|November 6, 2003
Expression of cathepsin D in urothelial carcinoma of the urinary bladder: an immunohistochemical study including correlations with extracellular matrix components, CD44, p53, Rb, c-erbB-2 and the proliferation indicesMichael J Droller
Urologic Oncology|February 22, 2021
Urologic Oncology: Seminars and Original Investigations. A Twenty-Fifth Anniversary HistoryMichael J Droller
Urology|October 1, 2005
Biological considerations in the assessment of urothelial cancer: a retrospectiveMichael J Droller
The Journal of Urology|August 12, 2005
Public education: the AUA and AUA foundationMichael J Droller
European Urology|December 7, 2007
Words of wisdom. Re: Surveillance for recurrent bladder cancer using a point-of-care proteomic assayMichael J Droller
Pageof 8